Naoyuki Kawao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Naoyuki Kawao has a total of 170 co-authors. Here are the top co-authors by number of shared publications:
- Hiroshi Kaji
Department of Physiology and Regenerative Medicine, Kindai University Faculty of Medicine, Osaka, Japan
36 shared publications - Osamu Matsuo
Department of Physiology and Regenerative Medicine, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan
36 shared publications Kiyotaka Okada
Department of Arts and Science, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan; Department of Physiology and Regenerative Medicine, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan
35 shared publications- Atsufumi Kawabata
Laboratory of Pharmacology and Pathophysiology, Faculty of Pharmacy, Kindai University
26 shared publications Katsumi Okumoto
Life Science Research Institute, Kindai University, Osaka-Sayama, Osaka 589-8511, Japan
23 shared publicationsYukinori Tamura
Department of Physiology and Regenerative Medicine, Kindai University Faculty of Medicine, Osakasayama, Japan
22 shared publications
Latest Publications
- Open Access
- 26 July 2026
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 10 (9)
The distinct roles of PTHrP and PTH1R in long bone growth and digit formation
PTH-related peptide (PTHrP) and its receptor, the PTH/PTHrP receptor type 1 (PTH1R), are essential for chondrocyte differentiation and epiphyseal cartilage homeostasis. To evaluate the functional differences between PTHrP and PTH1R derived from mesenchymal progenitor cells (MPCs) in skeletal development, we generated MPC-specific Pthrp conditional KO mice (PTHrP cKO; Prrx1-Cre; Pthrpflox/flox) or Pth1r cKO mice (PTH1R cKO; Prrx1-Cre; Pth1rflox/flox) using the Prrx1-Cre driver and analyzed their skeletal phenotypes. Both PTHrP cKO mice and PTH1R cKO mice exhibited severe shortening of long bones and impaired growth plate formation immediately after birth. However, in the digits, only PTHrP cKO mice showed distinctive digit deviations in the toes, which were similar to those seen in human diastrophic dysplasia (DTD). These results suggest that MPC-derived PTHrP and PTH1R play distinct roles. Both are essential for longitudinal bone growth, but PTHrP plays an important role in regulating toe position and morphology. This phenotypic difference suggests a novel PTH1R-independent function of PTHrP in skeletal development. Thus, our study provides genetic evidence for this mechanism, offering insights into the pathogenesis of congenital digit deformities such as those seen in DTD.
- 26 July 2026
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 10 (9)
Open AccessThe distinct roles of PTHrP and PTH1R in long bone growth and digit formation
PTH-related peptide (PTHrP) and its receptor, the PTH/PTHrP receptor type 1 (PTH1R), are essential for chondrocyte differentiation and epiphyseal cartilage homeostasis. To evaluate the functional differences between PTHrP and PTH1R derived from mesenchymal progenitor cells (MPCs) in skeletal development, we generated MPC-specific Pthrp conditional KO mice (PTHrP cKO; Prrx1-Cre; Pthrpflox/flox) or Pth1r cKO mice (PTH1R cKO; Prrx1-Cre; Pth1rflox/flox) using the Prrx1-Cre driver and analyzed their skeletal phenotypes. Both PTHrP cKO mice and PTH1R cKO mice exhibited severe shortening of long bones and impaired growth plate formation immediately after birth. However, in the digits, only PTHrP cKO mice showed distinctive digit deviations in the toes, which were similar to those seen in human diastrophic dysplasia (DTD). These results suggest that MPC-derived PTHrP and PTH1R play distinct roles. Both are essential for longitudinal bone growth, but PTHrP plays an important role in regulating toe position and morphology. This phenotypic difference suggests a novel PTH1R-independent function of PTHrP in skeletal development. Thus, our study provides genetic evidence for this mechanism, offering insights into the pathogenesis of congenital digit deformities such as those seen in DTD.
- Open Access
- 1 January 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (1) , 478
Role of Macrophages and Plasminogen Activator Inhibitor-1 in Delayed Bone Repair Induced by Glucocorticoids in Mice
Glucocorticoids delay fracture healing and induce osteoporosis. However, the mechanisms by which glucocorticoids delay bone repair have yet to be clarified. Plasminogen activator inhibitor-1 (PAI-1) is the principal inhibitor of plasminogen activators and an adipocytokine that regulates metabolism. We herein investigated the roles of macrophages in glucocorticoid-induced delays in bone repair after femoral bone injury using PAI-1-deficient female mice intraperitoneally administered with dexamethasone (Dex). Dex significantly decreased the number of F4/80-positive macrophages at the damaged site two days after femoral bone injury. It also attenuated bone injury-induced decreases in the number of hematopoietic stem cells in bone marrow in wild-type and PAI-1-deficient mice. PAI-1 deficiency significantly weakened Dex-induced decreases in macrophage number and macrophage colony-stimulating factor (M-CSF) mRNA levels at the damaged site two days after bone injury. It also significantly ameliorated the Dex-induced inhibition of macrophage phagocytosis at the damaged site. In conclusion, we herein demonstrated that Dex decreased the number of macrophages at the damaged site during early bone repair after femoral bone injury partly through PAI-1 and M-CSF in mice.
- 1 January 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (1) , 478
Open AccessRole of Macrophages and Plasminogen Activator Inhibitor-1 in Delayed Bone Repair Induced by Glucocorticoids in Mice
Glucocorticoids delay fracture healing and induce osteoporosis. However, the mechanisms by which glucocorticoids delay bone repair have yet to be clarified. Plasminogen activator inhibitor-1 (PAI-1) is the principal inhibitor of plasminogen activators and an adipocytokine that regulates metabolism. We herein investigated the roles of macrophages in glucocorticoid-induced delays in bone repair after femoral bone injury using PAI-1-deficient female mice intraperitoneally administered with dexamethasone (Dex). Dex significantly decreased the number of F4/80-positive macrophages at the damaged site two days after femoral bone injury. It also attenuated bone injury-induced decreases in the number of hematopoietic stem cells in bone marrow in wild-type and PAI-1-deficient mice. PAI-1 deficiency significantly weakened Dex-induced decreases in macrophage number and macrophage colony-stimulating factor (M-CSF) mRNA levels at the damaged site two days after bone injury. It also significantly ameliorated the Dex-induced inhibition of macrophage phagocytosis at the damaged site. In conclusion, we herein demonstrated that Dex decreased the number of macrophages at the damaged site during early bone repair after femoral bone injury partly through PAI-1 and M-CSF in mice.
- Open Access
- 6 April 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (7) , 2547
Roles of Dkk2 in the Linkage from Muscle to Bone during Mechanical Unloading in Mice
Mechanical unloading simultaneously induces muscle and bone loss, but its mechanisms are not fully understood. The interactions between skeletal muscle and bone have been recently noted. Although canonical wingless-related integration site (Wnt)/β-catenin signaling is crucial for bone metabolism, its roles in the muscle and bone interactions have remained unknown. Here, we performed comprehensive DNA microarray analyses to clarify humoral factors linking muscle to bone in response to mechanical unloading and hypergravity with 3 g in mice. We identified Dickkopf (Dkk) 2, a Wnt/β-catenin signaling inhibitor, as a gene whose expression was increased by hindlimb unloading (HU) and reduced by hypergravity in the soleus muscle of mice. HU significantly elevated serum Dkk2 levels and Dkk2 mRNA levels in the soleus muscle of mice whereas hypergravity significantly decreased those Dkk2 levels. In the simple regression analyses, serum Dkk2 levels were negatively and positively related to trabecular bone mineral density and mRNA levels of receptor activator of nuclear factor-kappa B ligand (RANKL) in the tibia of mice, respectively. Moreover, shear stress significantly suppressed Dkk2 mRNA levels in C2C12 cells, and cyclooxygenase inhibitors significantly antagonized the effects of shear stress on Dkk2 expression. On the other hand, Dkk2 suppressed the mRNA levels of osteogenic genes, alkaline phosphatase activity and mineralization, and it increased RANKL mRNA levels in mouse osteoblasts. In conclusion, we showed that muscle and serum Dkk2 levels are positively and negatively regulated during mechanical unloading and hypergravity in mice, respectively. An increase in Dkk2 expression in the skeletal muscle might contribute to disuse- and microgravity-induced bone and muscle loss.
- 6 April 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (7) , 2547
Open AccessRoles of Dkk2 in the Linkage from Muscle to Bone during Mechanical Unloading in Mice
Mechanical unloading simultaneously induces muscle and bone loss, but its mechanisms are not fully understood. The interactions between skeletal muscle and bone have been recently noted. Although canonical wingless-related integration site (Wnt)/β-catenin signaling is crucial for bone metabolism, its roles in the muscle and bone interactions have remained unknown. Here, we performed comprehensive DNA microarray analyses to clarify humoral factors linking muscle to bone in response to mechanical unloading and hypergravity with 3 g in mice. We identified Dickkopf (Dkk) 2, a Wnt/β-catenin signaling inhibitor, as a gene whose expression was increased by hindlimb unloading (HU) and reduced by hypergravity in the soleus muscle of mice. HU significantly elevated serum Dkk2 levels and Dkk2 mRNA levels in the soleus muscle of mice whereas hypergravity significantly decreased those Dkk2 levels. In the simple regression analyses, serum Dkk2 levels were negatively and positively related to trabecular bone mineral density and mRNA levels of receptor activator of nuclear factor-kappa B ligand (RANKL) in the tibia of mice, respectively. Moreover, shear stress significantly suppressed Dkk2 mRNA levels in C2C12 cells, and cyclooxygenase inhibitors significantly antagonized the effects of shear stress on Dkk2 expression. On the other hand, Dkk2 suppressed the mRNA levels of osteogenic genes, alkaline phosphatase activity and mineralization, and it increased RANKL mRNA levels in mouse osteoblasts. In conclusion, we showed that muscle and serum Dkk2 levels are positively and negatively regulated during mechanical unloading and hypergravity in mice, respectively. An increase in Dkk2 expression in the skeletal muscle might contribute to disuse- and microgravity-induced bone and muscle loss.
- Open Access
- 3 February 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (2) , e0228685
Roles of the vestibular system in obesity and impaired glucose metabolism in high-fat diet-fed mice
The vestibular system controls balance, posture, blood pressure, and gaze. However, the roles of the vestibular system in energy and glucose metabolism remain unknown. We herein examined the roles of the vestibular system in obesity and impaired glucose metabolism using mice with vestibular lesions (VL) fed a high-sucrose/high-fat diet (HSHFD). VL was induced by surgery or arsenic. VL significantly suppressed body fat enhanced by HSHFD in mice. Glucose intolerance was improved by VL in mice fed HSHFD. VL blunted the levels of adipogenic factors and pro-inflammatory adipokines elevated by HSHFD in the epididymal white adipose tissue of mice. A β-blocker antagonized body fat and glucose intolerance enhanced by HSHFD in mice. The results of an RNA sequencing analysis showed that HSHFD induced alterations in genes, such as insulin-like growth factor-2 and glial fibrillary acidic protein, in the vestibular nuclei of mice through the vestibular system. In conclusion, we herein demonstrated that the dysregulation of the vestibular system influences an obese state and impaired glucose metabolism induced by HSHFD in mice. The vestibular system may contribute to the regulation of set points under excess energy conditions.
- 3 February 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (2) , e0228685
Open AccessRoles of the vestibular system in obesity and impaired glucose metabolism in high-fat diet-fed mice
The vestibular system controls balance, posture, blood pressure, and gaze. However, the roles of the vestibular system in energy and glucose metabolism remain unknown. We herein examined the roles of the vestibular system in obesity and impaired glucose metabolism using mice with vestibular lesions (VL) fed a high-sucrose/high-fat diet (HSHFD). VL was induced by surgery or arsenic. VL significantly suppressed body fat enhanced by HSHFD in mice. Glucose intolerance was improved by VL in mice fed HSHFD. VL blunted the levels of adipogenic factors and pro-inflammatory adipokines elevated by HSHFD in the epididymal white adipose tissue of mice. A β-blocker antagonized body fat and glucose intolerance enhanced by HSHFD in mice. The results of an RNA sequencing analysis showed that HSHFD induced alterations in genes, such as insulin-like growth factor-2 and glial fibrillary acidic protein, in the vestibular nuclei of mice through the vestibular system. In conclusion, we herein demonstrated that the dysregulation of the vestibular system influences an obese state and impaired glucose metabolism induced by HSHFD in mice. The vestibular system may contribute to the regulation of set points under excess energy conditions.
- Open Access
- 24 October 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (10) , e0224403
Roles of leptin in the recovery of muscle and bone by reloading after mechanical unloading in high fat diet-fed obese mice
Muscle and bone masses are elevated by the increased mechanical stress associated with body weight gain in obesity. However, the mechanisms by which obesity affects muscle and bone remain unclear. We herein investigated the roles of obesity and humoral factors from adipose tissue in the recovery phase after reloading from disuse-induced muscle wasting and bone loss using normal diet (ND)- or high fat diet (HFD)-fed mice with hindlimb unloading (HU) and subsequent reloading. Obesity did not affect decreases in trabecular bone mineral density (BMD), muscle mass in the lower leg, or grip strength in HU mice. Obesity significantly increased trabecular BMD, muscle mass in the lower leg, and grip strength in reloading mice over those in reloading mice fed ND. Among the humoral factors in epididymal and subcutaneous adipose tissue, leptin mRNA levels were significantly higher in reloading mice fed HFD than in mice fed ND. Moreover, circulating leptin levels were significantly higher in reloading mice fed HFD than in mice fed ND. Leptin mRNA levels in epididymal adipose tissue or serum leptin levels positively correlated with the increases in trabecular BMD, total muscle mass, and grip strength in reloading mice fed ND and HFD. The present study is the first to demonstrate that obesity enhances the recovery of bone and muscle masses as well as strength decreased by disuse after reloading in mice. Leptin may contribute to the recovery of muscle and bone enhanced by obesity in mice.
- 24 October 2019
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (10) , e0224403
Open AccessRoles of leptin in the recovery of muscle and bone by reloading after mechanical unloading in high fat diet-fed obese mice
Muscle and bone masses are elevated by the increased mechanical stress associated with body weight gain in obesity. However, the mechanisms by which obesity affects muscle and bone remain unclear. We herein investigated the roles of obesity and humoral factors from adipose tissue in the recovery phase after reloading from disuse-induced muscle wasting and bone loss using normal diet (ND)- or high fat diet (HFD)-fed mice with hindlimb unloading (HU) and subsequent reloading. Obesity did not affect decreases in trabecular bone mineral density (BMD), muscle mass in the lower leg, or grip strength in HU mice. Obesity significantly increased trabecular BMD, muscle mass in the lower leg, and grip strength in reloading mice over those in reloading mice fed ND. Among the humoral factors in epididymal and subcutaneous adipose tissue, leptin mRNA levels were significantly higher in reloading mice fed HFD than in mice fed ND. Moreover, circulating leptin levels were significantly higher in reloading mice fed HFD than in mice fed ND. Leptin mRNA levels in epididymal adipose tissue or serum leptin levels positively correlated with the increases in trabecular BMD, total muscle mass, and grip strength in reloading mice fed ND and HFD. The present study is the first to demonstrate that obesity enhances the recovery of bone and muscle masses as well as strength decreased by disuse after reloading in mice. Leptin may contribute to the recovery of muscle and bone enhanced by obesity in mice.
- 7 September 2019
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 38 (2) , 161-171
Role of irisin in androgen-deficient muscle wasting and osteopenia in mice
Androgen deficiency plays a crucial role in the pathogenesis of male osteoporosis and sarcopenia. Myokines have recently been identified as humoral factors that are involved in the interactions between muscle and bone; however, the influence of androgen deficiency on these interactions remains unclear. Therefore, we herein investigated the roles of humoral factors linking muscle to bone using orchidectomized mice with sarcopenia and osteopenia. Orchidectomy (ORX) significantly reduced muscle mass, grip strength, and trabecular bone mineral density (BMD) in mice. Among the myokines examined, ORX only significantly reduced fibronectin type III domain-containing 5 (Fndc5) mRNA levels in both the soleus and gastrocnemius muscles of mice. In simple regression analyses, Fndc5 mRNA levels in the soleus muscle positively correlated with trabecular BMD, but not cortical BMD. The administration of irisin, a product of Fndc5, significantly protected against the decrease induced in trabecular BMD, but not muscle mass, by androgen deficiency in mice. In conclusion, the present results demonstrated that androgen deficiency decreases the expression of irisin in the skeletal muscle of mice. Irisin may be involved in muscle/bone relationships negatively affected by androgen deficiency.
- 7 September 2019
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 38 (2) , 161-171
Role of irisin in androgen-deficient muscle wasting and osteopenia in mice
Androgen deficiency plays a crucial role in the pathogenesis of male osteoporosis and sarcopenia. Myokines have recently been identified as humoral factors that are involved in the interactions between muscle and bone; however, the influence of androgen deficiency on these interactions remains unclear. Therefore, we herein investigated the roles of humoral factors linking muscle to bone using orchidectomized mice with sarcopenia and osteopenia. Orchidectomy (ORX) significantly reduced muscle mass, grip strength, and trabecular bone mineral density (BMD) in mice. Among the myokines examined, ORX only significantly reduced fibronectin type III domain-containing 5 (Fndc5) mRNA levels in both the soleus and gastrocnemius muscles of mice. In simple regression analyses, Fndc5 mRNA levels in the soleus muscle positively correlated with trabecular BMD, but not cortical BMD. The administration of irisin, a product of Fndc5, significantly protected against the decrease induced in trabecular BMD, but not muscle mass, by androgen deficiency in mice. In conclusion, the present results demonstrated that androgen deficiency decreases the expression of irisin in the skeletal muscle of mice. Irisin may be involved in muscle/bone relationships negatively affected by androgen deficiency.
- 2 November 2018
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 29 (6) , 959-963
Plasminogen activator inhibitor-1 is involved in interleukin-1β-induced matrix metalloproteinase expression in murine chondrocytes
Objectives: Interleukin (IL)-1β and matrix metalloproteinases (MMPs) play important roles in the pathogenesis of osteoarthritis. On the other hand, plasminogen activator inhibitor-1 (PAI-1), an inhibitor of fibrinolysis, exerts functions in the pathogenesis of various diseases. However, the functional roles of PAI-1 in the chondrocytes have been still remained unknown. Methods: In the present study, we investigated the roles of PAI-1 in the effects of IL-1β on the chondrocytes using wild-type and PAI-1-deficient mice. Results: IL-1β significantly elevated PAI-1 mRNA levels in the chondrocytes from wild-type mice. PAI-1 deficiency significantly blunted the mRNA levels of TGF-β and IL-6 enhanced by IL-1β in murine chondrocytes. Moreover, PAI-1 deficiency significantly decreased the mRNA levels of MMP-13, -3 and -9 as well as MMP-13 activity enhanced by IL-1β in the chondrocytes. In addition, PAI-1 deficiency significantly reversed type II collagen mRNA levels suppressed by IL-1β in the chondrocytes. On the other hand, active PAI-1 treatment significantly enhanced the mRNA levels of MMP-13, -3 and -9 as well as decreased type II collagen mRNA levels in the chondrocytes from wild-type mice. Conclusion: We first demonstrated that PAI-1 is involved in MMP expression enhanced by IL-1β in murine chondrocytes. PAI-1 might be crucial for the cartilage matrix degradation and the impaired chondrogenesis by IL-1β in mice.
- 2 November 2018
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 29 (6) , 959-963
Plasminogen activator inhibitor-1 is involved in interleukin-1β-induced matrix metalloproteinase expression in murine chondrocytes
Objectives: Interleukin (IL)-1β and matrix metalloproteinases (MMPs) play important roles in the pathogenesis of osteoarthritis. On the other hand, plasminogen activator inhibitor-1 (PAI-1), an inhibitor of fibrinolysis, exerts functions in the pathogenesis of various diseases. However, the functional roles of PAI-1 in the chondrocytes have been still remained unknown. Methods: In the present study, we investigated the roles of PAI-1 in the effects of IL-1β on the chondrocytes using wild-type and PAI-1-deficient mice. Results: IL-1β significantly elevated PAI-1 mRNA levels in the chondrocytes from wild-type mice. PAI-1 deficiency significantly blunted the mRNA levels of TGF-β and IL-6 enhanced by IL-1β in murine chondrocytes. Moreover, PAI-1 deficiency significantly decreased the mRNA levels of MMP-13, -3 and -9 as well as MMP-13 activity enhanced by IL-1β in the chondrocytes. In addition, PAI-1 deficiency significantly reversed type II collagen mRNA levels suppressed by IL-1β in the chondrocytes. On the other hand, active PAI-1 treatment significantly enhanced the mRNA levels of MMP-13, -3 and -9 as well as decreased type II collagen mRNA levels in the chondrocytes from wild-type mice. Conclusion: We first demonstrated that PAI-1 is involved in MMP expression enhanced by IL-1β in murine chondrocytes. PAI-1 might be crucial for the cartilage matrix degradation and the impaired chondrogenesis by IL-1β in mice.
- 1 November 2018
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (6) , 9687-9697
Plasminogen activator inhibitor‐1 deficiency suppresses osteoblastic differentiation of mesenchymal stem cells in mice
Plasminogen activator inhibitor‐1 (PAI‐1) is known as an inhibitor of fibrinolytic system. Previous studies suggest that PAI‐1 is involved in the pathogenesis of osteoporosis induced by ovariectomy, diabetes, and glucocorticoid excess in mice. However, the roles of PAI‐1 in early‐stage osteogenic differentiation have remained unknown. In the current study, we investigated the roles of PAI‐1 in osteoblastic differentiation of mesenchymal stem cells (MSCs) using wild‐type (WT) and PAI‐1‐deficient (PAI‐1 KO) mice. PAI‐1 mRNA levels were increased with time during osteoblastic differentiation of MSCs or mesenchymal ST‐2 cells. However, the increased PAI‐1 levels declined at the mineralization phase in the experiment using MC3T3‐E1 cells. PAI‐1 deficiency significantly blunted the expression of osteogenic gene, such as osterix and alkaline phosphatase enhanced by bone morphogenetic protein (BMP)‐2 in bone marrow‐derived MSCs (BM‐MSCs), adipose‐tissue‐derived MSCs (AD‐MSCs), and bone marrow stromal cells of mice. Moreover, a reduction in endogenous PAI‐1 levels by small interfering RNA significantly suppressed the expression of osteogenic gene in ST‐2 cells. Plasmin did not affect osteoblastic differentiation of AD‐MSCs induced by BMP‐2 with or without PAI‐1 deficiency. PAI‐1 deficiency and a reduction in endogenous PAI‐1 levels did not affect the phosphorylations of receptor‐specific Smads by BMP‐2 and transforming growth factor‐β in AD‐MSCs and ST‐2 cells, respectively. In conclusion, we first showed that PAI‐1 is crucial for the differentiation of MSCs into osteoblasts in mice.
- 1 November 2018
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (6) , 9687-9697
Plasminogen activator inhibitor‐1 deficiency suppresses osteoblastic differentiation of mesenchymal stem cells in mice
Plasminogen activator inhibitor‐1 (PAI‐1) is known as an inhibitor of fibrinolytic system. Previous studies suggest that PAI‐1 is involved in the pathogenesis of osteoporosis induced by ovariectomy, diabetes, and glucocorticoid excess in mice. However, the roles of PAI‐1 in early‐stage osteogenic differentiation have remained unknown. In the current study, we investigated the roles of PAI‐1 in osteoblastic differentiation of mesenchymal stem cells (MSCs) using wild‐type (WT) and PAI‐1‐deficient (PAI‐1 KO) mice. PAI‐1 mRNA levels were increased with time during osteoblastic differentiation of MSCs or mesenchymal ST‐2 cells. However, the increased PAI‐1 levels declined at the mineralization phase in the experiment using MC3T3‐E1 cells. PAI‐1 deficiency significantly blunted the expression of osteogenic gene, such as osterix and alkaline phosphatase enhanced by bone morphogenetic protein (BMP)‐2 in bone marrow‐derived MSCs (BM‐MSCs), adipose‐tissue‐derived MSCs (AD‐MSCs), and bone marrow stromal cells of mice. Moreover, a reduction in endogenous PAI‐1 levels by small interfering RNA significantly suppressed the expression of osteogenic gene in ST‐2 cells. Plasmin did not affect osteoblastic differentiation of AD‐MSCs induced by BMP‐2 with or without PAI‐1 deficiency. PAI‐1 deficiency and a reduction in endogenous PAI‐1 levels did not affect the phosphorylations of receptor‐specific Smads by BMP‐2 and transforming growth factor‐β in AD‐MSCs and ST‐2 cells, respectively. In conclusion, we first showed that PAI‐1 is crucial for the differentiation of MSCs into osteoblasts in mice.